ArticleFrontiers in immunology2024

Towards a survival risk prediction model for metastatic NSCLC patients on durvalumab using whole-lung CT radiomics.

Kedar A Patwardhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.